BioNTech SE (BNTX) Payables (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Payables data on file, last reported at $622.6 million in Q4 2025.

• In Q4 2025, Payables rose 36.55% year-over-year to $622.6 million; the TTM figure through Dec 2025 stood at $622.6 million (up 36.55% YoY), while the FY2025 annual figure was $604.3 million, up 32.54% from the prior year.
• Payables grew to $622.6 million in Q4 2025, from $512.4 million in the prior quarter.
• Across five years, Payables topped out at $949.3 million in Q2 2024 and bottomed at $34.3 million in Q1 2023.
• A 5-year average of $422.6 million and a median of $383.4 million in 2023 frame the typical range for Payables.
• Annual changes were most pronounced in 2023 — Payables slumped 89.04% — and 2024, when it jumped 852.35%.
• Year by year, Payables stood at $206.1 million in 2021, then rose by 2.05% to $210.4 million in 2022, then soared by 82.23% to $383.4 million in 2023, then gained by 18.94% to $456.0 million in 2024, then jumped by 36.55% to $622.6 million in 2025.
• The last three Payables figures came in at $622.6 million (Q4 2025), $512.4 million (Q3 2025), and $615.4 million (Q2 2025), per Business Quant data.

Peer Comparison